Authors:
McCloskey, E
Selby, P
De Takats, D
Bernard, J
Davies, M
Robinson, J
Francis, R
Adams, J
Pande, K
Beneton, M
Jalava, T
Loyttyniemi, E
Kanis, JA
Citation: E. Mccloskey et al., Effects of clodronate on vertebral fracture risk in osteoporosis: A 1-yearinterim analysis, BONE, 28(3), 2001, pp. 310-315
Citation: O. Johnell et al., Acute and long-term increase in fracture risk after hospitalization for vertebral fracture, OSTEOPOR IN, 12(3), 2001, pp. 207-214
Authors:
Ismail, AA
Cockerill, W
Cooper, C
Finn, JD
Abendroth, K
Parisi, G
Banzer, D
Benevolenskaya, LI
Bhalla, AK
Armas, JB
Cannata, JB
Delmas, PD
Dequeker, J
Dilsen, G
Eastell, R
Ershova, O
Falch, JA
Felsch, B
Havelka, S
Hoszowski, K
Jajic, I
Kragl, U
Johnell, O
Vaz, AL
Lorenc, R
Lyritis, G
Marchand, F
Masaryk, P
Matthis, C
Miazgowski, T
Pols, HAP
Poor, G
Rapado, A
Raspe, HH
Reid, DM
Reisinger, W
Janott, J
Scheidt-Nave, C
Stepan, J
Todd, C
Weber, K
Woolf, AD
Ambrecht, G
Gowin, W
Felsenberg, D
Lunt, M
Kanis, JA
Reeve, J
Silman, AJ
O'Neill, TW
Citation: Aa. Ismail et al., Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: Results from the European Prospective Osteoporosis Study, OSTEOPOR IN, 12(2), 2001, pp. 85-90
Authors:
Ashford, RU
Luchetti, M
McCloskey, EV
Gray, RL
Pande, KC
Dey, A
Kayan, K
Ralston, SH
Kanis, JA
Citation: Ru. Ashford et al., Studies of bone density, quantitative ultrasound, and vertebral fractures in relation to collagen type I alpha 1 alleles in elderly women, CALCIF TIS, 68(6), 2001, pp. 348-351
Citation: Ev. Mccloskey et al., The clinical and cost considerations of bisphosphonates in preventing bonecomplications in patients with metastatic breast cancer or multiple myeloma, DRUGS, 61(9), 2001, pp. 1253-1274
Authors:
McCloskey, EV
Dunn, JA
Kanis, JA
MacLennan, ICM
Drayson, MT
Citation: Ev. Mccloskey et al., Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma, BR J HAEM, 113(4), 2001, pp. 1035-1043
Authors:
Kanis, JA
Johnell, O
Oden, A
Jonsson, B
De Laet, C
Dawson, A
Citation: Ja. Kanis et al., Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis, BONE, 27(5), 2000, pp. 585-590
Authors:
Hordon, LD
Raisi, M
Aaron, JE
Paxton, SK
Beneton, M
Kanis, JA
Citation: Ld. Hordon et al., Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: I. Two-dimensional histology, BONE, 27(2), 2000, pp. 271-276
Authors:
Aaron, JE
Shore, PA
Shore, RC
Beneton, M
Kanis, JA
Citation: Je. Aaron et al., Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: II. Three-dimensional histology, BONE, 27(2), 2000, pp. 277-282
Authors:
Kanis, JA
Johnell, O
Oden, A
Jonsson, B
Dawson, A
Dere, W
Citation: Ja. Kanis et al., Risk of hip fracture derived from relative risks: An analysis applied to the population of Sweden, OSTEOPOR IN, 11(2), 2000, pp. 120-127
Authors:
Dey, A
McCloskey, EV
Taube, T
Cox, R
Panda, KC
Ashford, RU
Forster, M
de Takats, D
Kanis, JA
Citation: A. Dey et al., Metacarpal morphometry using a semi-automated technique in the assessment of osteoporosis and vertebral fracture risk, OSTEOPOR IN, 11(11), 2000, pp. 953-958
Citation: Ja. Kanis et Ev. Mccloskey, Bisphosphonates in the treatment of multiple myeloma, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 457-481